Elanco Animal Health Inc
Gesloten
SectorGezondheidszorg
23.98 3.5
Overzicht
Wijziging aandelenprijs
24u
Min
23.47
Max
24.19
Inkomsten | 289M 57M |
|---|---|
Verkoop | 227M 1.4B |
K/W Sectorgemiddelde | 372.714 49.712 |
EPS | 0.4 |
Winstmarge | 4.158 |
Werknemers | 9,400 |
EBITDA | 138M 144M |
Aanbevelingen | Strong Buy |
|---|---|
12 Maanden Prognose | +28% upside |
Volgende Winsten | 6 aug 2026 |
|---|
Marktkapitalisatie | 891M 12B |
|---|---|
Vorige openingsprijs | 20.48 |
Vorige sluitingsprijs | 23.98 |
Nieuwssentiment
By Acuity
40%
60%
114 / 342 Rangschikking in Healthcare
Elanco Animal Health Inc Grafiek
Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.
Over Elanco Animal Health Inc
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.